RNGBX | RNPFX | RNGBX / RNPFX | |
Total Expense Ratio | 1.50 | 0.46 | 326% |
Annual Report Gross Expense Ratio | 1.50 | 0.46 | 326% |
Fund Existence | 23 years | 23 years | - |
Gain YTD | 15.890 | 15.974 | 99% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.2B | 158B | 25% |
Annual Yield % from dividends | 0.00 | 0.72 | - |
Returns for 1 year | 12.13 | 15.49 | 78% |
Returns for 3 years | 55.08 | 49.63 | 111% |
Returns for 5 years | 29.16 | 36.59 | 80% |
Returns for 10 years | 69.78 | 100.52 | 69% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LFSC | 28.94 | 0.41 | +1.44% |
F/m Emerald Life Sciences Innovation ETF | |||
QVOY | 27.38 | 0.19 | +0.72% |
Q3 All-Season Active Rotation ETF | |||
QVMS | 28.18 | 0.12 | +0.43% |
Invesco S&P SmallCp 600 QVM Mlt-fctr ETF | |||
SCHG | 30.80 | -0.03 | -0.10% |
Schwab US Large-Cap Growth ETF™ | |||
KIE | 58.86 | -0.66 | -1.11% |
SPDR® S&P Insurance ETF |